Seikagaku Corporation operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Seikagaku with three other
companies in this sector in Japan:
Aska Pharmaceutical Company Limited
sales of 43.22 billion Japanese Yen [US$377.27 million]
of which 90%
was Pharmaceutical Products Business),
Nippon Chemiphar Co., Ltd.
(35.60 billion Japanese Yen [US$310.81 million]
of which 97%
was Pharmaceutical Business), and
Eiken Chemical Co., Ltd.
(32.16 billion Japanese Yen [US$280.78 million]
of which 56%
was Immunoserology Test Agent).
Seikagaku reported sales of ¥30.96 billion (US$270.30 million)
March of 2016.
increase of 4.9%
versus 2015, when the company's sales were ¥29.52 billion.
Sales of Lal saw an increase
that was more than double the company's growth rate: sales were up
11.6% in 2016, from
¥4.88 billion to ¥5.44 billion.